Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
NYSE:BMY
Price:
43.99 USD
0.66%
Market Closed
Updated:
May 4, 2024
Bristol-Myers Squibb Co
Income from Continuing Operations
|
Bristol-Myers Squibb Co
Income from Continuing Operations Peer Comparison
Comparables:
JNJ
PFE
MRK
ZTS
LLY
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Income from Continuing Operations
-$6.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Income from Continuing Operations
$17.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
1%
|
|
|
Pfizer Inc
NYSE:PFE
|
Income from Continuing Operations
-$254m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Income from Continuing Operations
$2.3B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-7%
|
|
|
Zoetis Inc
NYSE:ZTS
|
Income from Continuing Operations
$2.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
17%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Income from Continuing Operations
$6.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
18%
|
CAGR 10-Years
5%
|
See Also
What is Bristol-Myers Squibb Co's Income from Continuing Operations?
Income from Continuing Operations
-6.1B
USD
-6.1B
USD
Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's Income from Continuing Operations amounts to -6.1B USD.
What is Bristol-Myers Squibb Co's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
0%
0%
You don't have any saved screeners yet
